NIO, CORT & UMC - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action

Loading...
Loading...

NEW YORK, April 18, 2019 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss, you can request that the Court appoint you as lead plaintiff.  Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

NIO Inc. (NYSE: NIO)
Class Period: September 12, 2018 - March 5, 2019
Deadline:
May 13, 2019
For more info:
www.bgandg.com/nio

The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements and/or failed to disclose that: (1) NIO would not be building its own manufacturing plant and would instead continue to rely on a little-known Chinese state-owned auto manufacturer, JAC Auto, to manufacture its electric vehicles; (2) reductions in government subsidies for electric cars would materially impact NIO's sales; and (3) as a result, defendants' statements about NIO's business, operations, and prospects were materially false and misleading at all relevant times.

Corcept Therapeutics Incorporated CORT 
Class Period:
August 2, 2017 - February 5, 2019
Deadline: May 13, 2019
For more info:
www.bgandg.com/cort

The Complaint alleges that Defendants made materially false and misleading statements and/or failed to disclose that: (1) Corcept had improperly paid doctors to promote its drug, Korlym; (2) Corcept aggressively promoted Korlym for off-label uses; (3) Corcept's sole specialty pharmacy was a related party; (4) Corcept artificially inflated its revenue and sales using illicit sales practices through a related party; (5) such practices were reasonably likely to lead to regulatory scrutiny; and (6) as a result, defendants' positive statements about Corcept's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

United Microelectronics Corp. UMC
Class Period: October 28, 2015 - November 1, 2018
Deadline:
May 13, 2019
For more info:
www.bgandg.com/umc

The Complaint alleges that Defendants made materially false and misleading statements and/or failed to disclose that:  (1) UMC conspired with Fujian to steal trade secrets from Micron relating to its research and development of DRAM; (2) UMC hired former Micron employees for the purpose of stealing such information from Micron; (3) the foregoing conduct placed UMC and certain of its employees at an increased risk of criminal and regulatory investigation by the U.S. government; and (4) as a result, UMC's public statements were materially false and misleading at all relevant times.

Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

Loading...
Loading...
Posted In: NewsLegalPress Releases
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...